What are the bleeding risks associated with ticagrelor compared to clopidogrel in the treatment of peripheral artery disease?
Year: 2026
Type: article
Abstract: Current evidence indicates no significant difference in major bleeding risk between ticagrelor and clopidogrel in patients with peripheral artery disease, though ticagrelor may have a higher incidence of minor bleeding.
Author: Tripdatabase
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7230088046
